Compare ETG & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ETG | PAHC |
|---|---|---|
| Founded | N/A | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 2003 | 2014 |
| Metric | ETG | PAHC |
|---|---|---|
| Price | $21.66 | $50.03 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $34.33 |
| AVG Volume (30 Days) | 106.6K | ★ 226.9K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.95% |
| EPS Growth | N/A | ★ 1883.33 |
| EPS | N/A | ★ 1.32 |
| Revenue | N/A | ★ $833,350,000.00 |
| Revenue This Year | N/A | $17.03 |
| Revenue Next Year | N/A | $3.82 |
| P/E Ratio | ★ N/A | $38.48 |
| Revenue Growth | N/A | ★ 4.12 |
| 52 Week Low | $15.04 | $16.16 |
| 52 Week High | $23.67 | $56.30 |
| Indicator | ETG | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 30.88 | 52.10 |
| Support Level | $20.80 | $49.74 |
| Resistance Level | $21.80 | $56.14 |
| Average True Range (ATR) | 0.35 | 2.19 |
| MACD | -0.15 | -0.80 |
| Stochastic Oscillator | 19.05 | 41.40 |
Eaton Vance Tax Advgd Gbl Div Inc Fd is a diversified, closed-end management investment company. Its investment objective is to provide a high level of after-tax total return consisting of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of aerospace and defense, capital markets, diversified telecommunication services, electrical equipment, biotechnology, banks, and other areas.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.